title: [Experience in the administration of vasobral in sensorineural vascular hypoasusis].
abstract: 24 patients with neurosensory hypoacusis of vascular genesis related to chronic cerebral vascular deficiency in the vertebrobasillar bed combined with cervical osteochondrosis were given basobral. The drug produced positive changes in neurological symptoms, lowered hearing thresholds in the range of high frequencies, improved cerebral hemodynamics and hearing afferentation at the stem level of the acoustic analyzer.
authors.forename: A B
authors.initials: AB
authors.lastname: Grinshteĭn
authors.forename: N A
authors.initials: NA
authors.lastname: Shnaĭder
authors.forename: O K
authors.initials: OK
authors.lastname: Kromm
authors.forename: M V
authors.initials: MV
authors.lastname: Pavlovskaia
mesh_terms: D000284:Administration, Oral; D000328:Adult; D002110:Caffeine / Q000008:administration & dosage / Q000627:therapeutic use*; D004088:Dihydroergotoxine / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004338:Drug Combinations; D006319:Hearing Loss, Sensorineural / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D010007:Osteochondritis / Q000150:complications; D012189:Retrospective Studies; D014715:Vertebrobasilar Insufficiency / Q000150:complications*
chemical_list: D004338:Drug Combinations; D018696:Neuroprotective Agents; D004088:Dihydroergotoxine; D002110:Caffeine; C055581:Vasobral